Carregant...
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm
OBJECTIVE: Rupture of abdominal aortic aneurysms (AAA) is a devastating event potentially preventable by therapies that inhibit growth of small aneurysms. Receptor of advanced glycation end products (RAGE) has been implicated in age related diseases including atherosclerosis and Alzheimer’s. Consequ...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921961/ https://ncbi.nlm.nih.gov/pubmed/19652591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0b013e3181b41a18 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|